Loading...
XNYS
TRLV
Market cap1.93bUSD
, Last price  
USD
Name

Trulieve Cannabis Corp

Chart & Performance

D1W1MN
XNYS:TRLV chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
10.09%
Rev. gr., 5y
18.17%
Revenues
1.20b
+1.30%
161,14519,778,344102,816,631252,818,591521,533,000938,385,0001,239,800,0001,129,193,0001,186,490,0001,201,857,186
Net income
-118m
L-23.65%
0042,967,792178,032,76362,998,00018,032,000-205,100,000-526,796,000-155,105,000-118,418,311
CFO
278m
+2.25%
0024,962,80023,514,20899,643,00012,898,00023,096,000201,841,000271,484,000277,596,877

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
URL
https://www.trulieve.com
IPO date
Sep 25, 2018
Employees
5,900
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT